Skip to main content

Month: September 2021

Nova Leap Health Corp. places No. 42 on The Globe and Mail’s third-annual ranking of Canada’s Top Growing Companies

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Sept. 24, 2021 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a leading home health care organization, is pleased to announce that it placed No. 42 on the 2021 Report on Business ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Nova Leap earned its spot with three-year growth of 1,533%. “We’re pleased to once again be recognized as one of the fastest growing companies in Canada,” said Chris Dobbin, President & CEO of Nova Leap. “It’s a credit to our incredible team and a testament to the important work we do in service of our seniors and their families every day.” About Canada’s Top Growing Companies Launched...

Continue reading

PetVivo Holdings to Present at Emerging Growth Conference on September 29, 2021

PetVivo Holdings, Inc.Mr. LaiPetVivo Holdings, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. MINNEAPOLIS, MN, US, Sept. 24, 2021 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that it has been invited to present at the Emerging Growth Conference on September 29, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s Chief Executive Officer, John Lai in real time. Mr. Lai will provide a presentation and may subsequently open...

Continue reading

B2Digital Heads Back to Bowling Green for 17 Explosive MMA Matchups in B2FS 134 This Saturday, September 25

Tampa, FL, Sept. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that the B2 Fighting Series (“B2FS”) will return to the Sloan Convention Center in Bowling Green, Kentucky this Saturday night for another supercharged night of pulse-pounding MMA action at B2FS 134. What:  B2 Fighting Series 134, Amateur and Professional LIVE MMAWhere:  Sloan Convention Center in Bowling Green, KentuckyWhen:  Saturday, September 25. Doors open at 6pm ET. PPV Broadcast starts at 7pm ET. VIP tickets for the event have already sold out. General Admission tickets have nearly sold out, but there will be limited availability for tickets at the door. Interested fans will also be able to stream it...

Continue reading

America First Multifamily Investors, L.P. Announces Pricing of its Public Offering of Beneficial Unit Certificates

OMAHA, Neb., Sept. 24, 2021 (GLOBE NEWSWIRE) — America First Multifamily Investors, L.P. (NASDAQ: ATAX) (the “Partnership”) today announced that it has priced its previously announced underwritten public offering of 4,750,000 beneficial unit certificates (“BUCs”) representing assigned limited partnership interests at a price to the public of $6.10 per BUC. The offering is expected to close on or about September 28, 2021, subject to customary closing conditions. The Partnership has granted the underwriters a 30-day option to purchase up to an additional 712,500 BUCs in connection with the offering. Total estimated gross proceeds of the offering are approximately $29.0 million or approximately $33.3 million if the underwriters exercise their option to purchase additional shares in full. The Partnership intends to utilize the net...

Continue reading

American Films Announces Intention to Conduct a 1:5 Reverse Stock Split, Shares to Commence Trading on tZERO ATS in the Fourth Quarter

Latest moves demonstrate company’s commitment to increasing shareholder value by focusing on asset digitization in the form of STO and NFT issuance NEW BOSTON, N.H., Sept. 24, 2021 (GLOBE NEWSWIRE) — American Films, Inc. (OTC: AMFL) today announced that its Board of Directors unanimously approved a 1:5 reverse stock split. The effective date of the reverse stock split will be determined once it has been processed by the Financial Industry Regulatory Authority (“FINRA”). “We believe that the reverse stock split is an important step for the company and its stockholders to optimize our position as we work to execute strategic initiatives across all fronts,” said American Films President and Chief Executive Officer John Carty. “By implementing a reverse stock split, American Films believes it can realize increased incremental demand...

Continue reading

Nanox to Host Live Streaming AI Vision Event

Join the Company on Wednesday October 27th at 8:30am ET to hear about its AI vision and how it can enhance its deep technology Ran Poliakine, Chairman and CEO and Erez Meltzer, Director, will host industry experts and Nanox team members to share the Company’s AI vision of the integration of the AI technologies with the Nanox.ARC and Nanox.SOURCE NEVE ILAN, Israel, Sept. 24, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Ran Poliakine, Chairman and Chief Executive Officer, and Erez Meltzer, Director (appointed CEO effective January 1, 2022), will host a Nanox AI Vision event. Wednesday, October 27, 20218:30am ETPublic link for the event: https://nanox.eventmagix.com/ About Nanox:Nanox, founded by the...

Continue reading

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross proceeds of CAD$10 million (the “Private Placement”). Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant. Each Warrant will entitle the holder to purchase one Common Share at an exercise price of CAD$0.80...

Continue reading

Catalyst Biosciences to Present at the Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that a fireside chat including members of its executive management team will be broadcast as part of the Cantor Global Healthcare Conference at 10:00 am ET on Wednesday, September 29, 2021. To access the webcast of the discussion, please click here. An archived webcast of the discussion will be available for 90 days on the Events and Presentations section of Catalyst’s website. About Catalyst Biosciences, the Protease Medicines companyCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Our protease engineering platform has generated two late-stage clinical programs, including MarzAA, a...

Continue reading

Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common Stock

NEWTOWN, Pa., Sept. 24, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $4.20 per share. The gross proceeds of the offering to the Company are expected to be $21 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. In addition, Onconova granted the underwriters a thirty-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about September 28, 2021, subject to the satisfaction...

Continue reading

KYN Capital Group Launches Corporate Website

CARSON CITY, NV, Sept. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – KYN Capital Group (OTC: KYNC), home to one of the most awaited crypto exchanges and super apps in the United States, is proud to announce the launch of its corporate website which is now live.    By visiting kyncap.com you can now stay abreast of product launches, investor calls, and key initiatives taking place at the company. You will also find a list of satellite offices, partners, and corporate leaders that are helping to drive the company forward in a new direction. With the launch of its new website, KYN Capital Group has made its vision clear to clients, as well as investors, its path forward under CEO, Rick Wilson.  As stated in a recent announcement, “Rick believes now is the time for KYN Capital Group to solidify its place in the market while also creating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.